SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Calidi Biotherapeutics raises $1.2M via registered direct offering

Calidi Biotherapeutics sold 1,025,640 common shares at $1.17 per share, generating about $1.2 million in gross proceeds. The offering closed September 21, 2026.

CLDI

Calidi Biotherapeutics entered into a Stock Purchase Agreement to raise capital through a registered direct offering. The company sold 1,025,640 shares of common stock at $1.17 per share, generating approximately $1.2 million in gross proceeds. The offering closed on September 21, 2026, with no und…

Related stories